Nassim Djebli
Basel, BS 4051, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Dose Recommendation of Remimazolam Tosilate for General Anesthesia in Children and Adolescents: Synergistic Combination of PopPK and PBPK Approaches.
Journal: Pharmaceutics
Published: December 16, 2025
Population Pharmacokinetics of Trastuzumab Rezetecan in Patients With HER2-Expressing or Mutated Advanced Solid Tumors.
Journal: CPT: pharmacometrics & systems pharmacology
Published: October 20, 2025
Population pharmacokinetic modeling of dexmedetomidine nasal spray in Chinese adults.
Journal: Frontiers in pharmacology
Published: July 09, 2025
Prediction of a CLDN18.2 Targeted Antibody Drug Conjugate Pharmacokinetics in Cancer Patients Using PBPK Modeling and Simulation.
Journal: CPT: pharmacometrics & systems pharmacology
Published: February 26, 2025
Middle-Out Physiologically Based Pharmacokinetic Modeling to Support Pediatric Dosing Recommendation for Alectinib.
Journal: CPT: pharmacometrics & systems pharmacology
Published: October 25, 2024
Population pharmacokinetics of adebrelimab - Support of alternative flat dose regimen in extensive-stage small-cell lung cancer.
Journal: CPT: pharmacometrics & systems pharmacology
Published: January 17, 2024
Evaluation of the potential impact on pharmacokinetics of various cytochrome P450 substrates of increasing IL-6 levels following administration of the T-cell bispecific engager glofitamab.
Journal: CPT: pharmacometrics & systems pharmacology
Published: September 23, 2023
Entrectinib dose confirmation in pediatric oncology patients: pharmacokinetic considerations.
Journal: Cancer chemotherapy and pharmacology
Published: August 04, 2022
Combined Semi-mechanistic Target-Mediated Drug Disposition and Pharmacokinetic-Pharmacodynamic Models of Alirocumab, PCSK9, and Low-Density Lipoprotein Cholesterol in a Pooled Analysis of Randomized Phase I/II/III Studies.
Journal: European journal of drug metabolism and pharmacokinetics
Published: July 05, 2022
Efficacy and safety exposure-response analyses of entrectinib in patients with advanced or metastatic solid tumors.
Journal: Cancer chemotherapy and pharmacology
Published: October 01, 2021
Physiologically-Based Pharmacokinetic Modelling of Entrectinib Parent and Active Metabolite to Support Regulatory Decision-Making.
Journal: European journal of drug metabolism and pharmacokinetics
Published: August 17, 2021
Population Pharmacokinetics and Pharmacodynamics of Meropenem in Critically Ill Patients: How to Achieve Best Dosage Regimen According to the Clinical Situation.
Journal: European journal of drug metabolism and pharmacokinetics
Published: July 25, 2021
Last Updated: 09/26/2026